![]()
|
|
||||||||
(Received for publication, March 11, 1997, and in revised form, May 30, 1997)
From the Departments of The glucocorticoid receptor (GR) can both
activate and repress transcription of target genes by interaction with
specific genomic response elements, glucocorticoid response elements
(GREs). Activation of transcription is usually the result of the direct interaction between GR and the GRE, whereas GR-mediated transcription repression is either the result of the indirect action of GR, mediated
by a response element as a result of protein·protein interaction or
by an occlusion mechanism in which GR displaces a general or regulatory
transcription factor. A specific mutation of rat GR, K461A, has
previously been described to transform the indirect protein·protein
interaction-dependent transrepressive effect of GR into an
activating function (Starr, D. B., Matsui, W., Thomas, J. R.,
and Yamamoto, K. R. (1996) Genes Dev. 10, 1271-1283). In HOS D4 and COS7 cells, this mutation was shown to transform the
transrepressive effect of wild-type GR, acting on reporter constructs
containing the composite GRE from the proliferin gene (plfG) or the
negative tethering GRE from the collagenase A promoter (colA), into an
activating function. In contrast, the K461A mutation had no effect on
the transrepressive effect of GR on the human osteocalcin gene in
which repression apparently occurs through the binding of GR to a
negative GRE that overlaps the TATA box. The transrepressive function,
typically 40% of the basal level in the absence of hormone, required
only the isolated DNA-binding domain of wild type or mutant GR and was
independent of the nature of transactivation domain. Thus, mutation of
rat GR at position 461 differentiates between transrepressive functions
of GR dependent on GR·DNA interaction (repression by occlusion) and
GR·protein interaction (active repression).
Volume 272, Number 34,
Issue of August 22, 1997
pp. 21090-21095
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
§
,
Medical Nutrition and
§ Biosciences, Novum, Karolinska Institutet, Huddinge
Hospital, S-141 86 Huddinge, Sweden and ¶ Departments of
Cellular and Molecular Pharmacology, and Biochemistry and
Biophysics, PIBS Biochemistry and Molecular Biology Program, University
of California San Francisco,
San Francisco, California 94143-0450
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
O. Latchoumanin, V. Mynard, J. Devin-Leclerc, M.-A. Dugue, X. Bertagna, and M. G. Catelli Reversal of Glucocorticoids-Dependent Proopiomelanocortin Gene Inhibition by Leukemia Inhibitory Factor Endocrinology, January 1, 2007; 148(1): 422 - 432. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Koyanagi, H. Suyama, Y. Kuramoto, N. Matsunaga, H. Takane, S. Soeda, H. Shimeno, S. Higuchi, and S. Ohdo Glucocorticoid Regulation of 24-Hour Oscillation in Interferon Receptor Gene Expression in Mouse Liver Endocrinology, November 1, 2006; 147(11): 5034 - 5040. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Martens, S. Bilodeau, M. Maira, Y. Gauthier, and J. Drouin Protein-Protein Interactions and Transcriptional Antagonism between the Subfamily of NGFI-B/Nur77 Orphan Nuclear Receptors and Glucocorticoid Receptor Mol. Endocrinol., April 1, 2005; 19(4): 885 - 897. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Tse, B. A. Marroquin, D. R. Dorscheid, and S. R. White {beta}-Adrenergic agonists inhibit corticosteroid-induced apoptosis of airway epithelial cells Am J Physiol Lung Cell Mol Physiol, August 1, 2003; 285(2): L393 - L404. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Doppler, M. Windegger, C. Soratroi, J. Tomasi, J. Lechner, S. Rusconi, A. C. B. Cato, T. Almlöf, J. Liden, S. Okret, et al. Expression Level-Dependent Contribution of Glucocorticoid Receptor Domains for Functional Interaction with STAT5 Mol. Cell. Biol., May 1, 2001; 21(9): 3266 - 3279. [Abstract] [Full Text] |
||||
![]() |
I. P. Torra, V. Tsibulsky, F. Delaunay, R. Saladin, V. Laudet, J.-C. Fruchart, V. Kosykh, and B. Staels Circadian and Glucocorticoid Regulation of Rev-erb{alpha} Expression in Liver Endocrinology, October 1, 2000; 141(10): 3799 - 3806. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Meyer, M. Kneissel, J. Mariani, and B. Fournier In vitro and in vivo evidence for orphan nuclear receptor RORalpha function in bone metabolism PNAS, July 12, 2000; (2000) 150246097. [Abstract] [Full Text] |
||||
![]() |
F. Verrey Early aldosterone action: toward filling the gap between transcription and transport Am J Physiol Renal Physiol, September 1, 1999; 277(3): F319 - F327. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Aarnisalo, H. Santti, H. Poukka, J. J. Palvimo, and O. A. Jänne Transcription Activating and Repressing Functions of the Androgen Receptor Are Differentially Influenced by Mutations in the Deoxyribonucleic Acid-Binding Domain Endocrinology, July 1, 1999; 140(7): 3097 - 3105. [Abstract] [Full Text] |
||||
![]() |
N. Subramaniam, W. Cairns, and S. Okret Glucocorticoids Repress Transcription from a Negative Glucocorticoid Response Element Recognized by Two Homeodomain-containing Proteins, Pbx and Oct-1 J. Biol. Chem., September 4, 1998; 273(36): 23567 - 23574. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. J. Shah, J. A. Iniguez-Lluhi, A. Romanelli, S. R. Kimball, and L. S. Jefferson The Activated Glucocorticoid Receptor Modulates Presumptive Autoregulation of Ribosomal Protein S6 Protein Kinase, p70 S6K J. Biol. Chem., January 18, 2002; 277(4): 2525 - 2533. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Meyer, M. Kneissel, J. Mariani, and B. Fournier In vitro and in vivo evidence for orphan nuclear receptor RORalpha function in bone metabolism PNAS, August 1, 2000; 97(16): 9197 - 9202. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |